Skip to content

Assessment of the efficacy of EEG-based MI-BCI with robotic hand feedback after stroke

Assessment of the efficacy of EEG-based MI-BCI with robotic hand feedback after stroke: a preliminary analysis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041119
Enrollment
Unknown
Registered
2020-12-18
Start date
2020-12-07
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

1:MI-BCI therapy+standard conventional
2:standard conventional treatment

Sponsors

The Third Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patients with cerebral infarction for the first time met the diagnostic criteria for stroke in the 2015 Chinese classification of cerebrovascular diseases, and were confirmed as unilateral brain lesions by CT or MRI; 2. Patients aged 18 to 75 years; 3. Patients with 6 weeks 21 points); 6. Patients who signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with two or more stroke histories; 2. Patients with limb dysfunction caused by other reasons before onset; 3. Patients with shoulder and hand fracture pain; 4. Patients with comprehension disorder, vision disorder, hearing disorder, complete aphasia and severe cognitive impairment, other musculoskeletal and neurological diseases that affect functional recovery and can not collect RRG signal; 5. Patients undergoing other clinical central nervous intervention.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment-Upper Extremities Assessment;Wolf Motor Function Test;the Modified Barthel Index;EEG data;

Countries

China

Contacts

Public ContactLi Xin

The Third Affiliated Hospital of Sun Yat-Sen University

sumslixin@qq.com+86 13570385033

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026